Ebola History & Major Outbreaks: A Complete Timeline
From the forests of Central Africa in 1976 to the catastrophic West Africa epidemic — and what we've learned.
The 1976 Discovery: Two Outbreaks, One Virus
In late August 1976, a schoolteacher named Mabalo Lokela fell ill in Yambuku, a small mission-hospital town in what was then Zaire (now the Democratic Republic of the Congo). He had recently returned from a trip near the Ebola River. Within weeks, nearly every person who had received an injection at Yambuku Mission Hospital had died — the hospital's five syringes were being reused without sterilization, creating a perfect amplification chain.
Simultaneously — and entirely independently — an outbreak was raging 850 km away in Nzara, Sudan. By the time both outbreaks were contained, 318 people had died in Zaire (case fatality rate 88%) and 151 in Sudan (CFR 53%). Scientists named the new virus after the Ebola River near Yambuku.
Ebola Species: Not All Are Equal
Five distinct Ebola virus species have been identified, with significantly different mortality profiles:
| Species | Average CFR | Geographic range |
|---|---|---|
| Zaire ebolavirus (EBOV) | 60–90% | DRC, Rep. of Congo, Gabon |
| Sudan ebolavirus (SUDV) | 40–65% | Sudan, Uganda |
| Bundibugyo ebolavirus (BDBV) | 25–36% | Uganda |
| Taï Forest ebolavirus (TAFV) | Low (1 human case) | Côte d'Ivoire |
| Reston ebolavirus (RESTV) | Non-pathogenic to humans | Philippines/Asia |
Major Outbreaks Timeline
1976 — Yambuku, Zaire & Nzara, Sudan
Cases: 602 | Deaths: 431 | CFR: ~72%
First known outbreaks. Nosocomial amplification via unsterilized syringes in Yambuku. Both outbreaks ended when traditional burial practices were modified and the hospitals temporarily closed.
1989 — Reston, Virginia, USA
Human cases: 0 (4 workers seroconverted, no illness)
Reston ebolavirus discovered in imported macaques from the Philippines at a primate facility in Reston, Virginia. The virus was lethal to monkeys but did not cause illness in infected humans. The incident was dramatized in Richard Preston's book The Hot Zone.
1995 — Kikwit, DRC
Cases: 315 | Deaths: 254 | CFR: 81%
A major outbreak that put Ebola on the global radar. Initial spread through Kikwit General Hospital before WHO launched a major international response. The outbreak highlighted the critical role of healthcare worker protection and contact tracing.
2000–2001 — Uganda
Cases: 425 | Deaths: 224 | CFR: 53%
First major outbreak of Sudan ebolavirus in Uganda (Gulu, Masindi, Mbarara districts). The outbreak demonstrated the importance of early patient isolation and personal protective equipment for healthcare workers.
2014–2016 — West Africa (LARGEST EVER)
Cases: 28,652 | Deaths: 11,325 | CFR: 40%
The defining Ebola catastrophe of modern times. A 2-year-old child in Méliandou, Guinea — now called "Patient Zero" — likely acquired the infection from bats in a hollow tree used as a play space. From there, the virus spread to Sierra Leone, Liberia, and briefly to Nigeria, Senegal, Mali, the US, UK, Spain, and Italy.
Why it was different: Previous outbreaks were in remote rural areas. The 2014 epidemic reached Monrovia (population 1.5 million), Freetown, and Conakry — densely packed cities with porous borders, inadequate healthcare systems, and traditional burial practices that involved touching the body. Ebola remains transmissible for up to 7 days after death.
International response failures: WHO was criticized for an initial slow response; the emergency was not declared a Public Health Emergency of International Concern (PHEIC) until August 8, 2014 — months after international epidemiologists had raised alarms. Thousands of excess deaths occurred across all three countries from other causes (malaria, maternal mortality) because healthcare systems collapsed.
Legacy: The outbreak accelerated development of Ervebo vaccine, prompted creation of the WHO Health Emergencies Programme, and led to the Coalition for Epidemic Preparedness Innovations (CEPI).
2018–2020 — North Kivu & Ituri, DRC (Second Largest)
Cases: 3,481 | Deaths: 2,299 | CFR: 66%
The second-largest Ebola outbreak in history, complicated by active armed conflict in the DRC's eastern provinces. Health workers were attacked, Ebola Treatment Centres were burned down, and communities had deep mistrust of official health authorities — sometimes fuelled by misinformation and political manipulation.
First large-scale deployment of the Ervebo (rVSV-ZEBOV) vaccine in a ring vaccination strategy. Despite extraordinary challenges, the outbreak was declared over in June 2020.
2021 — Guinea (Resurgence)
Cases: 23 | Deaths: 12 | CFR: 52%
Over five years after the West Africa epidemic, Ebola re-emerged in Guinea. Genomic sequencing revealed it was not from a new spillover event from bats, but from a persistent survivor who had cleared the acute infection years earlier. The virus had remained latent — likely in immune-privileged sites — for at least 5 years before causing a new chain of transmission. This was a landmark finding with major implications for long-term survivor monitoring.
2022 — Uganda (Sudan Ebolavirus)
Cases: 164 | Deaths: 55 | CFR: 33%
A Sudan ebolavirus outbreak in Mubende and Kampala districts, Uganda. Of particular concern: no approved vaccine exists for Sudan ebolavirus. Ervebo protects against Zaire ebolavirus only. WHO fast-tracked investigational vaccines, but the outbreak ended through public health measures alone before efficacy trials could be completed.
The Natural Reservoir: Fruit Bats
Despite decades of searching, the definitive natural reservoir of Ebola virus in the wild has not been confirmed with certainty. The strongest evidence points to Pteropus fruit bats and other bat species. The virus has been detected in bat tissues, and communities living near bat roosts have higher rates of serological evidence of exposure.
Spillover events to humans typically involve contact with infected animal carcasses (especially great apes, which are highly susceptible to Ebola and die in large numbers during outbreaks), or direct bat exposure through hunting, meat handling, or cave exploration.
Transmission and Control Basics
Ebola spreads through direct contact with bodily fluids (blood, vomit, diarrhea, sweat, semen) of a symptomatic or recently deceased person. It is not airborne in the traditional sense. The basic reproductive number (R0) in uncontrolled community settings has been estimated at 1.5–2.5, falling dramatically with isolation and safe burials.
The three pillars of Ebola outbreak control are: (1) Case finding and isolation; (2) Contact tracing and monitoring; (3) Safe and dignified burials (SDB). When all three are implemented effectively, outbreaks can be controlled even without vaccines.
Vaccines and Treatments (2025 Status)
Ervebo (rVSV-ZEBOV-GP): FDA-approved December 2019 for Zaire ebolavirus in adults. Efficacy approximately 97.5% in the Guinea Ring Vaccination trial. Used under compassionate use in North Kivu 2018–2020 before formal approval.
Zabdeno/Mvabea: Two-dose vaccine approved in Europe. Ad26.ZEBOV prime followed by MVA-BN-Filo boost. Provides broader coverage including additional filoviruses.
Inmazeb (atoltivimab/maftivimab/odesivimab): Triple monoclonal antibody combination, FDA-approved October 2020. Reduced mortality from 49% to 24% in the PALM trial compared to ZMapp.
Ebanga (ansuvimab): Single monoclonal antibody, FDA-approved December 2020. Reduced mortality from 49% to 35% in the PALM trial. Simpler to administer than Inmazeb.
Lessons from 50 Years of Ebola
- Speed matters: Early declaration and rapid response prevent logarithmic case growth
- Community trust is essential: Outbreaks sustained by community resistance cannot be quelled by medical measures alone
- Healthcare worker protection is both ethical and epidemiological: Each HCW infected multiplies chains of transmission
- Survivors are a resource, not a risk: Survivor programs, long-term monitoring, and psychosocial support are critical
- Virus can persist in survivors: Sexual transmission from male survivors (detectable semen virus up to 500 days), CNS persistence, and rare relapsing disease require ongoing surveillance
- Strong health systems are the best defense: All major outbreaks occurred in countries with severely underfunded public health infrastructure
Get Outbreak Alerts
regularly updated infectious disease outbreak notifications, delivered free to your inbox.
Frequently Asked Questions
Ebola was first identified in 1976 in simultaneous outbreaks in Nzara, Sudan and Yambuku, Democratic Republic of the Congo. The virus was named after the Ebola River near Yambuku. Patient Zero in Yambuku was a schoolteacher who had returned from a trip near the river.
The 2014–2016 West Africa outbreak was the largest ever, with over 28,000 cases and 11,000 deaths across Guinea, Liberia, and Sierra Leone. It was the first to spread through densely populated urban areas and to reach multiple countries simultaneously, including brief exportations to the US, UK, Spain, and Italy.
There are now two FDA-approved treatments: Inmazeb (triple monoclonal antibody) and Ebanga (single monoclonal antibody), both approved in 2020 for Zaire ebolavirus. Neither is a cure but both significantly reduce mortality when given early. Supportive care — IV fluids, electrolyte management, treating secondary infections — remains the cornerstone of survival.
Ebola is not transmitted through the air under natural conditions. Transmission requires direct contact with infected bodily fluids (blood, vomit, diarrhea, sweat, semen) from a symptomatic person or a body that has recently died from Ebola. A corpse in the first days after death is especially infectious because viral load is at its peak.
Sources: WHO Ebola disease outbreak news; CDC Ebola history; NEJM Guinea outbreak genomics (Keïta et al.); PALM trial results (NEJM 2019); Lancet West Africa epidemic analyses.
Related: Ebola disease page · Mpox Guide 2025 · What is Ebola?